• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高拷贝数变异、特定转录因子和低免疫共同促成了前列腺癌细胞的干性。

High copy number variations, particular transcription factors, and low immunity contribute to the stemness of prostate cancer cells.

机构信息

College of Life Sciences, Nanjing Normal University, Nanjing, Jiangsu, China.

出版信息

J Transl Med. 2021 May 13;19(1):206. doi: 10.1186/s12967-021-02870-x.

DOI:10.1186/s12967-021-02870-x
PMID:33985534
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8117623/
Abstract

BACKGROUND

Tumor metastasis is the main cause of death of cancer patients, and cancer stem cells (CSCs) is the basis of tumor metastasis. However, systematic analysis of the stemness of prostate cancer cells is still not abundant. In this study, we explore the effective factors related to the stemness of prostate cancer cells by comprehensively mining the multi-omics data from TCGA database.

METHODS

Based on the prostate cancer transcriptome data in TCGA, gene expression modules that strongly relate to the stemness of prostate cancer cells are obtained with WGCNA and stemness scores. Copy number variation of stemness genes of prostate cancer is calculated and the difference of transcription factors between prostate cancer and normal tissues is evaluated by using CNV (copy number variation) data and ATAC-seq data. The protein interaction network of stemness genes in prostate cancer is constructed using the STRING database. Meanwhile, the correlation between stemness genes of prostate cancer and immune cells is analyzed.

RESULTS

Prostate cancer with higher Gleason grade possesses higher cell stemness. The gene set highly related to prostate cancer stemness has higher CNV in prostate cancer samples than that in normal samples. Although the transcription factors of stemness genes have similar expressions, they have different contributions between normal and prostate cancer tissues; and particular transcription factors enhance the stemness of prostate cancer, such as PUM1, CLOCK, SP1, TCF12, and so on. In addition, the lower tumor immune microenvironment is conducive to the stemness of prostate cancer. CD8 + T cells and M1 macrophages may play more important role in the stemness of prostate cancer than other immune cells in the tumor microenvironment. Finally, EZH2 is found to play a central role in stemness genes and is negatively correlated with resting mast cells and positively correlated with activated memory CD4 + T cells.

CONCLUSIONS

Based on the systematic and combined analysis of multi-omics data, we find that high copy number variation, specific transcription factors, and low immune microenvironment jointly contribute to the stemness of prostate cancer cells. These findings may provide us new clues and directions for the future research on stemness of prostate cancer.

摘要

背景

肿瘤转移是癌症患者死亡的主要原因,而癌症干细胞(CSC)是肿瘤转移的基础。然而,对前列腺癌细胞干性的系统分析仍然不够丰富。在这项研究中,我们通过综合挖掘 TCGA 数据库中的多组学数据,探讨与前列腺癌细胞干性相关的有效因素。

方法

基于 TCGA 前列腺癌转录组数据,使用 WGCNA 获得与前列腺癌细胞干性密切相关的基因表达模块,并计算前列腺癌干性基因的拷贝数变异,利用 CNV(拷贝数变异)数据和 ATAC-seq 数据评估前列腺癌与正常组织之间转录因子的差异。使用 STRING 数据库构建前列腺癌干性基因的蛋白质相互作用网络。同时,分析前列腺癌干性基因与免疫细胞的相关性。

结果

具有较高 Gleason 分级的前列腺癌具有更高的细胞干性。与前列腺癌干性高度相关的基因集在前列腺癌样本中的 CNV 高于正常样本。尽管干性基因的转录因子表达相似,但在正常和前列腺癌组织中具有不同的作用;并且特定的转录因子增强了前列腺癌的干性,如 PUM1、CLOCK、SP1、TCF12 等。此外,较低的肿瘤免疫微环境有利于前列腺癌的干性。肿瘤微环境中的 CD8+T 细胞和 M1 巨噬细胞可能比其他免疫细胞在前列腺癌干性中发挥更重要的作用。最后,发现 EZH2 在干性基因中起核心作用,与静止肥大细胞呈负相关,与激活的记忆性 CD4+T 细胞呈正相关。

结论

基于多组学数据的系统综合分析,我们发现高拷贝数变异、特定转录因子和低免疫微环境共同促进了前列腺癌细胞的干性。这些发现可能为我们未来研究前列腺癌干性提供新的线索和方向。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2cec/8117623/0e7040cceef7/12967_2021_2870_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2cec/8117623/26d7b64fb7fd/12967_2021_2870_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2cec/8117623/1f8b71421522/12967_2021_2870_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2cec/8117623/31bb40b9fe60/12967_2021_2870_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2cec/8117623/7c287c7a5971/12967_2021_2870_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2cec/8117623/0e7040cceef7/12967_2021_2870_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2cec/8117623/26d7b64fb7fd/12967_2021_2870_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2cec/8117623/1f8b71421522/12967_2021_2870_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2cec/8117623/31bb40b9fe60/12967_2021_2870_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2cec/8117623/7c287c7a5971/12967_2021_2870_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2cec/8117623/0e7040cceef7/12967_2021_2870_Fig5_HTML.jpg

相似文献

1
High copy number variations, particular transcription factors, and low immunity contribute to the stemness of prostate cancer cells.高拷贝数变异、特定转录因子和低免疫共同促成了前列腺癌细胞的干性。
J Transl Med. 2021 May 13;19(1):206. doi: 10.1186/s12967-021-02870-x.
2
Comprehensive data mining reveals RTK/RAS signaling pathway as a promoter of prostate cancer lineage plasticity through transcription factors and CNV.全面的数据挖掘揭示了 RTK/RAS 信号通路通过转录因子和 CNV 促进前列腺癌谱系可塑性。
Sci Rep. 2024 May 22;14(1):11688. doi: 10.1038/s41598-024-62256-z.
3
A novel tumor purity and immune infiltration-related model for predicting distant metastasis-free survival in prostate cancer.一种新型的肿瘤纯度和免疫浸润相关模型,用于预测前列腺癌的无远处转移生存。
Eur J Med Res. 2023 Nov 28;28(1):545. doi: 10.1186/s40001-023-01522-8.
4
Identification of a novel stemness-related signature with appealing implications in discriminating the prognosis and therapy responses for prostate cancer.鉴定一个新型的与前列腺癌预后和治疗反应相关的干性相关特征,具有明显的鉴别意义。
Cancer Genet. 2023 Aug;276-277:48-59. doi: 10.1016/j.cancergen.2023.07.005. Epub 2023 Jul 17.
5
Analysis of Bulk RNA Sequencing Data Reveals Novel Transcription Factors Associated With Immune Infiltration Among Multiple Cancers.批量 RNA 测序数据分析揭示了多种癌症中与免疫浸润相关的新型转录因子。
Front Immunol. 2021 Aug 20;12:644350. doi: 10.3389/fimmu.2021.644350. eCollection 2021.
6
Stemness Related Genes Revealed by Network Analysis Associated With Tumor Immune Microenvironment and the Clinical Outcome in Lung Adenocarcinoma.通过网络分析揭示的与肺腺癌肿瘤免疫微环境及临床结局相关的干性相关基因
Front Genet. 2020 Sep 16;11:549213. doi: 10.3389/fgene.2020.549213. eCollection 2020.
7
Multi-omics analysis reveals a macrophage-related marker gene signature for prognostic prediction, immune landscape, genomic heterogeneity, and drug choices in prostate cancer.多组学分析揭示了一个与巨噬细胞相关的标记基因特征,可用于前列腺癌的预后预测、免疫图谱、基因组异质性和药物选择。
Front Immunol. 2023 Apr 14;14:1122670. doi: 10.3389/fimmu.2023.1122670. eCollection 2023.
8
Low-density lipoprotein receptor promotes crosstalk between cell stemness and tumor immune microenvironment in breast cancer: a large data-based multi-omics study.低密度脂蛋白受体促进乳腺癌中细胞干性与肿瘤免疫微环境的串扰:基于大数据的多组学研究。
J Transl Med. 2023 Nov 30;21(1):871. doi: 10.1186/s12967-023-04699-y.
9
An Integrative Multi-Omics Analysis Based on Nomogram for Predicting Prostate Cancer Bone Metastasis Incidence.基于列线图的综合多组学分析预测前列腺癌骨转移发生率。
Genet Res (Camb). 2022 Sep 29;2022:8213723. doi: 10.1155/2022/8213723. eCollection 2022.
10
Identifying significant genetic regulatory networks in the prostate cancer from microarray data based on transcription factor analysis and conditional independency.基于转录因子分析和条件独立性,从微阵列数据中识别前列腺癌中的重要遗传调控网络。
BMC Med Genomics. 2009 Dec 21;2:70. doi: 10.1186/1755-8794-2-70.

引用本文的文献

1
Predicting hepatocellular carcinoma outcomes and immune therapy response with ATP-dependent chromatin remodeling-related genes, highlighting MORF4L1 as a promising target.利用ATP依赖的染色质重塑相关基因预测肝细胞癌的预后和免疫治疗反应,强调MORF4L1作为一个有前景的靶点。
Cancer Cell Int. 2025 Jan 5;25(1):4. doi: 10.1186/s12935-024-03629-2.
2
Putative Dual Roles of Bone Morphogenetic Protein 8B (BMP8B) in Disease Progression of Gastric Cancer.骨形态发生蛋白8B(BMP8B)在胃癌疾病进展中的潜在双重作用
Cancer Diagn Progn. 2024 Sep 1;4(5):567-578. doi: 10.21873/cdp.10365. eCollection 2024 Sep-Oct.
3
Comprehensive data mining reveals RTK/RAS signaling pathway as a promoter of prostate cancer lineage plasticity through transcription factors and CNV.

本文引用的文献

1
RUVBL1 is an amplified epigenetic factor promoting proliferation and inhibiting differentiation program in head and neck squamous cancers.RUVBL1 是一种扩增的表观遗传因子,可促进头颈部鳞状细胞癌的增殖并抑制分化程序。
Oral Oncol. 2020 Dec;111:104930. doi: 10.1016/j.oraloncology.2020.104930. Epub 2020 Jul 31.
2
Integrating the immune microenvironment of prostate cancer induced bone disease.整合前列腺癌骨病诱导的免疫微环境。
Mol Carcinog. 2020 Jul;59(7):822-829. doi: 10.1002/mc.23192. Epub 2020 Mar 31.
3
B cells, plasma cells and antibody repertoires in the tumour microenvironment.
全面的数据挖掘揭示了 RTK/RAS 信号通路通过转录因子和 CNV 促进前列腺癌谱系可塑性。
Sci Rep. 2024 May 22;14(1):11688. doi: 10.1038/s41598-024-62256-z.
4
A statistical learning method for simultaneous copy number estimation and subclone clustering with single-cell sequencing data.一种用于单细胞测序数据的拷贝数估计和亚克隆聚类的统计学习方法。
Genome Res. 2024 Feb 7;34(1):85-93. doi: 10.1101/gr.278098.123.
5
Multi-omics approach for identifying CNV-associated lncRNA signatures with prognostic value in prostate cancer.用于鉴定在前列腺癌中具有预后价值的与拷贝数变异相关的长链非编码RNA特征的多组学方法。
Noncoding RNA Res. 2023 Oct 10;9(1):66-75. doi: 10.1016/j.ncrna.2023.10.001. eCollection 2024 Mar.
6
EMT-related gene risk model establishment for prognosis and drug treatment efficiency prediction in hepatocellular carcinoma.建立 EMT 相关基因风险模型预测肝细胞癌的预后和药物治疗效果。
Sci Rep. 2023 Nov 21;13(1):20380. doi: 10.1038/s41598-023-47886-z.
7
Prostate Cancer Stem Cells: Biology and Treatment Implications.前列腺癌干细胞:生物学和治疗意义。
Int J Mol Sci. 2023 Oct 4;24(19):14890. doi: 10.3390/ijms241914890.
8
ScRNA-seq revealed an immunosuppression state and tumor microenvironment heterogeneity related to lymph node metastasis in prostate cancer.单细胞RNA测序揭示了前列腺癌中与淋巴结转移相关的免疫抑制状态和肿瘤微环境异质性。
Exp Hematol Oncol. 2023 May 23;12(1):49. doi: 10.1186/s40164-023-00407-0.
9
CAPN8 involves with exhausted, inflamed, and desert immune microenvironment to influence the metastasis of thyroid cancer.钙蛋白酶 8 参与耗尽、炎症和荒漠免疫微环境影响甲状腺癌转移。
Front Immunol. 2022 Oct 27;13:1013049. doi: 10.3389/fimmu.2022.1013049. eCollection 2022.
10
HAUS5 Is A Potential Prognostic Biomarker With Functional Significance in Breast Cancer.HAUS5是一种在乳腺癌中具有功能意义的潜在预后生物标志物。
Front Oncol. 2022 Feb 25;12:829777. doi: 10.3389/fonc.2022.829777. eCollection 2022.
肿瘤微环境中的 B 细胞、浆细胞和抗体库。
Nat Rev Immunol. 2020 May;20(5):294-307. doi: 10.1038/s41577-019-0257-x. Epub 2020 Jan 27.
4
Identification of potential biomarkers and pivotal biological pathways for prostate cancer using bioinformatics analysis methods.使用生物信息学分析方法鉴定前列腺癌的潜在生物标志物和关键生物学途径。
PeerJ. 2019 Oct 4;7:e7872. doi: 10.7717/peerj.7872. eCollection 2019.
5
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock.通过破坏生物钟靶向神经胶质瘤干细胞。
Cancer Discov. 2019 Nov;9(11):1556-1573. doi: 10.1158/2159-8290.CD-19-0215. Epub 2019 Aug 27.
6
Nomograms Predict Survival Advantages of Gleason Score 3+4 Over 4+3 for Prostate Cancer: A SEER-Based Study.列线图预测前列腺癌中Gleason评分3+4相对于4+3的生存优势:一项基于监测、流行病学和最终结果(SEER)数据库的研究
Front Oncol. 2019 Jul 16;9:646. doi: 10.3389/fonc.2019.00646. eCollection 2019.
7
Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype.基于图的基因组比对和基因分型与 HISAT2 和 HISAT-genotype。
Nat Biotechnol. 2019 Aug;37(8):907-915. doi: 10.1038/s41587-019-0201-4. Epub 2019 Aug 2.
8
CD8 T cells regulate tumour ferroptosis during cancer immunotherapy.CD8 T 细胞在癌症免疫治疗中调节肿瘤铁死亡。
Nature. 2019 May;569(7755):270-274. doi: 10.1038/s41586-019-1170-y. Epub 2019 May 1.
9
Cancer stemness, intratumoral heterogeneity, and immune response across cancers.癌症干性、肿瘤内异质性和跨癌症的免疫反应。
Proc Natl Acad Sci U S A. 2019 Apr 30;116(18):9020-9029. doi: 10.1073/pnas.1818210116. Epub 2019 Apr 17.
10
BRCA1 and EZH2 cooperate in regulation of prostate cancer stem cell phenotype.BRCA1 和 EZH2 合作调节前列腺癌干细胞表型。
Int J Cancer. 2019 Dec 1;145(11):2974-2985. doi: 10.1002/ijc.32323. Epub 2019 May 10.